Topiramate Alternatives Compared
Topiramate Remove Topiramate from your drug comparison | Topamax Remove Topamax from your drug comparison | Propranolol Remove Propranolol from your drug comparison |
---|
Topiramate Remove Topiramate from your drug comparison | Topamax topiramate Remove Topamax from your drug comparison | Propranolol Remove Propranolol from your drug comparison | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Topiramate may be prescribed either alone or in combination with other medications for the treatment of certain types of epilepsy, or it may be given for the prevention of migraines. Drowsiness is a... View more |
Topamax may be prescribed either alone or in combination with other medications for the treatment of certain types of epilepsy, or it may be given for the prevention of migraine. Drowsiness is a... View more |
Propranolol is mainly used for blood pressure and angina control; however, it also has a role in migraine prevention and the treatment of essential tremor. Propranolol may cause vivid dreams and is... View more |
||||||||||||||||||||||||
Prescription only |
Prescription only |
Prescription only |
||||||||||||||||||||||||
Ratings & Reviews |
||||||||||||||||||||||||||
Drug Class |
||||||||||||||||||||||||||
Side Effects |
||||||||||||||||||||||||||
Commonly reported side effects include: anxiety, ataxia, confusion, diarrhea, diplopia, dizziness, drowsiness, dysphasia, fatigue, lack of concentration, memory impairment, nausea, nervousness, paresthesia, psychomotor disturbance, speech disturbance, depression, visual disturbance, weight loss, dysgeusia, mood changes, anorexia. See the full topiramate side effects document. |
Common side effects include: anxiety, ataxia, confusion, diarrhea, diplopia, dizziness, drowsiness, dysphasia, fatigue, lack of concentration, memory impairment, nausea, nervousness, paresthesia, psychomotor disturbance, speech disturbance, depression, visual disturbance, weight loss, dysgeusia, mood changes, anorexia. See the full Topamax side effects document. |
See the full propranolol side effects document. |
||||||||||||||||||||||||
Pricing and Coupons* Prices are without insurance |
||||||||||||||||||||||||||
View all topiramate prices |
View all Topamax prices and generic prices |
View all propranolol prices |
||||||||||||||||||||||||
Generic Availability |
||||||||||||||||||||||||||
Yes (this medicine) |
Yes (this medicine) |
|||||||||||||||||||||||||
Dosage Form(s) Available |
||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names |
||||||||||||||||||||||||||
Qudexy XR, Topamax, Trokendi XR | Other topiramate brands include: Qudexy XR, Trokendi XR | Hemangeol, Inderal LA, Inderal XL, InnoPran XL | ||||||||||||||||||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
||||||||||||||||||||||||||
56 hours |
56 hours |
6.4 hours |
||||||||||||||||||||||||
CSA Schedule**View glossary of terms. |
||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category |
||||||||||||||||||||||||||
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
||||||||||||||||||||||||
FDA Alerts |
||||||||||||||||||||||||||
N/A |
||||||||||||||||||||||||||
Drug Interactions |
||||||||||||||||||||||||||
A total of 264 drugs are known to interact with topiramate:
|
A total of 264 drugs are known to interact with Topamax:
|
A total of 517 drugs are known to interact with propranolol:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions |
||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Disease Interactions |
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
First Approval Date |
||||||||||||||||||||||||||
December 24, 1996 |
December 24, 1996 |
November 13, 1967 |
||||||||||||||||||||||||
WADA ClassView World Anti-Doping Agency classifications. |
||||||||||||||||||||||||||
N/A |
N/A |
|||||||||||||||||||||||||
More Information |
||||||||||||||||||||||||||
Consumer Resources |
||||||||||||||||||||||||||
Professional Resources |
||||||||||||||||||||||||||
Related Treatment Guide |
||||||||||||||||||||||||||
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.